Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Hubei Xingfa Chemicals Group Gelecekteki Büyüme

Future kriter kontrolleri 1/6

Hubei Xingfa Chemicals Group kazanç ve gelirin sırasıyla yıllık 19% ve 7.5% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 18.8% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 9.8% olacağı tahmin edilmektedir.

Anahtar bilgiler

19.0%

Kazanç büyüme oranı

18.8%

EPS büyüme oranı

Chemicals kazanç büyümesi	33.7%
Gelir büyüme oranı	7.5%
Gelecekteki özkaynak getirisi	9.8%
Analist kapsamı	Good
Son güncelleme	04 Sep 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Some Investors May Be Worried About Hubei Xingfa Chemicals Group's (SHSE:600141) Returns On Capital

Sep 09

Market Still Lacking Some Conviction On Hubei Xingfa Chemicals Group Co., Ltd. (SHSE:600141)

Jul 17

Does Hubei Xingfa Chemicals Group (SHSE:600141) Have A Healthy Balance Sheet?

Jun 11

Hubei Xingfa Chemicals Group (SHSE:600141) Will Want To Turn Around Its Return Trends

May 21

Benign Growth For Hubei Xingfa Chemicals Group Co., Ltd. (SHSE:600141) Underpins Its Share Price

Apr 05

Kazanç ve Gelir Büyüme Tahminleri

SHSE:600141 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CNY Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2026	33,808	2,560	4,730	5,108	5
12/31/2025	31,739	2,155	4,804	5,514	6
12/31/2024	29,808	1,839	2,933	4,338	6
6/30/2024	27,819	1,564	-711	1,483	N/A
3/31/2024	28,422	1,311	-869	1,451	N/A
12/31/2023	28,105	1,379	-979	1,453	N/A
9/30/2023	26,393	1,946	-776	1,672	N/A
6/30/2023	26,702	2,822	978	3,241	N/A
3/31/2023	28,118	4,559	2,443	5,040	N/A
12/31/2022	30,311	5,852	4,520	6,884	N/A
9/30/2022	31,993	6,654	6,837	8,830	N/A
6/30/2022	31,285	6,760	5,617	7,860	N/A
3/31/2022	28,168	5,668	4,535	6,258	N/A
12/31/2021	23,902	4,282	3,827	5,356	N/A
9/30/2021	19,863	2,800	2,574	4,039	N/A
6/30/2021	18,893	1,655	2,115	3,272	N/A
3/31/2021	18,908	953	1,742	2,725	N/A
12/31/2020	18,317	621	1,480	2,405	N/A
9/30/2020	18,812	361	371	830	N/A
6/30/2020	17,872	315	497	993	N/A
3/31/2020	17,592	280	56	985	N/A
12/31/2019	18,039	302	-49	1,036	N/A
9/30/2019	18,000	312	813	2,108	N/A
6/30/2019	17,969	342	518	1,698	N/A
3/31/2019	18,119	378	886	1,842	N/A
12/31/2018	17,855	402	945	1,899	N/A
9/30/2018	18,155	469	941	2,049	N/A
6/30/2018	17,248	393	1,573	2,514	N/A
3/31/2018	16,006	358	N/A	2,070	N/A
12/31/2017	15,761	318	N/A	2,006	N/A
9/30/2017	15,833	264	N/A	1,618	N/A
6/30/2017	15,834	177	N/A	1,337	N/A
3/31/2017	15,373	119	N/A	1,113	N/A
12/31/2016	14,541	102	N/A	1,146	N/A
9/30/2016	12,963	50	N/A	547	N/A
6/30/2016	12,337	60	N/A	513	N/A
3/31/2016	12,552	70	N/A	687	N/A
12/31/2015	12,392	77	N/A	739	N/A
9/30/2015	12,586	122	N/A	953	N/A
6/30/2015	12,388	510	N/A	803	N/A
3/31/2015	11,882	502	N/A	667	N/A
12/31/2014	11,392	494	N/A	665	N/A
9/30/2014	11,149	406	N/A	261	N/A
6/30/2014	10,941	13	N/A	321	N/A
3/31/2014	10,789	1	N/A	369	N/A
12/31/2013	10,934	58	N/A	229	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 600141 'nin tahmini kazanç büyümesi (yıllık 19% ) tasarruf oranının ( 2.9% ) üzerindedir.

Kazançlar ve Piyasa: 600141 şirketinin kazançlarının (yıllık 19% ) CN pazarından (yıllık 23.2% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: 600141 şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.

Gelir ve Pazar: 600141 şirketinin gelirinin (yıllık 7.5% ) CN pazarından (yıllık 13.2% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Geliri: 600141 şirketinin gelirinin (yıllık 7.5% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 600141 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 9.8 %).

Hubei Xingfa Chemicals Group Gelecekteki Büyüme

Future kriter kontrolleri 1/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Consensus EPS estimates fall by 43%

Consensus EPS estimates fall by 20%

Price target decreased by 8.1% to CN¥33.79

Price target decreased by 9.1% to CN¥37.03

Price target decreased by 9.1% to CN¥37.03

Price target decreased to CN¥45.75

Recent updates

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q3, 2024 Results on Oct 26, 2024

Investor sentiment improves as stock rises 17%

Some Investors May Be Worried About Hubei Xingfa Chemicals Group's (SHSE:600141) Returns On Capital

Second quarter 2024 earnings released: EPS: CN¥0.39 (vs CN¥0.15 in 2Q 2023)

Market Still Lacking Some Conviction On Hubei Xingfa Chemicals Group Co., Ltd. (SHSE:600141)

Hubei Xingfa Chemicals Group Co., Ltd. to Report First Half, 2024 Results on Aug 20, 2024

Dividend of CN¥0.60 announced

Does Hubei Xingfa Chemicals Group (SHSE:600141) Have A Healthy Balance Sheet?

Hubei Xingfa Chemicals Group (SHSE:600141) Will Want To Turn Around Its Return Trends

First quarter 2024 earnings released: EPS: CN¥0.34 (vs CN¥0.40 in 1Q 2023)

Benign Growth For Hubei Xingfa Chemicals Group Co., Ltd. (SHSE:600141) Underpins Its Share Price

New major risk - Financial position

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024

Investor sentiment improves as stock rises 16%

Hubei Xingfa Chemicals Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 02, 2024

Hubei Xingfa Chemicals' Controlling Shareholder Plans to Raise its Holdings in the Company

Consensus EPS estimates fall by 43%

New major risk - Revenue and earnings growth

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q3, 2023 Results on Oct 28, 2023

Consensus EPS estimates fall by 20%

Price target decreased by 8.1% to CN¥33.79

New minor risk - Profit margin trend

New major risk - Revenue and earnings growth

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q2, 2023 Results on Aug 21, 2023

Price target decreased by 9.1% to CN¥37.03

Price target decreased by 9.1% to CN¥37.03

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Price target decreased to CN¥45.75

Third quarter 2022 earnings released: EPS: CN¥1.17 (vs CN¥1.20 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥1.73 (vs CN¥0.70 in 2Q 2021)

Price target increased to CN¥51.33

Investor sentiment deteriorated over the past week

Price target increased to CN¥49.56

Investor sentiment improved over the past week

Price target increased to CN¥45.41

Investor sentiment improved over the past week

Consensus EPS estimates increase by 14%

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment improved over the past week

Price target increased to CN¥44.89

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥1.10 (vs CN¥0.22 in 3Q 2020)

Investor sentiment deteriorated over the past week

Hubei Xingfa Chemicals Group Co., Ltd. (SHSE:600141) signed an Equity Purchase Agreement to acquire additional 18.785% minority stake in Hubei Taisheng Chemical Co., Ltd. from ABC Financial Asset Investment Co., Ltd. for approximately CNY 510 million.

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Consensus EPS estimates increase to CN¥1.66

Second quarter 2021 earnings released: EPS CN¥0.70 (vs CN¥0.14 in 2Q 2020)

Consensus forecasts updated

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.32 (vs CN¥0.02 in 1Q 2020)

Consensus forecasts updated

Full year 2020 earnings released: EPS CN¥0.61 (vs CN¥0.33 in FY 2019)

New 90-day high: CN¥14.78

New 90-day high: CN¥13.77

New 90-day high: CN¥12.40

Third quarter earnings released

Hubei Xingfa Chemicals Group Co., Ltd. to Report Q3, 2020 Results on Oct 16, 2020

Analysts lower EPS estimates to CN¥0.35

Earnings released

New 90-day high - CN¥11.85

New 90-day high - CN¥10.59

Hubei Xingfa Chemicals Group Co., Ltd. to Report First Half, 2020 Results on Aug 25, 2020

Kazanç ve Gelir Büyüme Tahminleri

Analist Gelecek Büyüme Tahminleri

Hisse Başına Kazanç Büyüme Tahminleri